Bill Would Stop Medicare Payments To Unlicensed Orthotics Providers
This article was originally published in The Gray Sheet
Executive Summary
Reps. Glenn ‘GT’ Thompson, R-Pa., and Mike Thompson, D-Calif., have introduced legislation banning CMS from reimbursing unaccredited or unlicensed orthotics and prosthetics providers. The bill comes after a report, commissioned by the American Orthotic and Prosthetic Association, showed that CMS’ efforts to eliminate payments to unlicensed providers have been ineffective.
You may also be interested in...
Reimbursement Briefs: OIG, CMS Address DME; Cigna Genetic Testing Policy Takes Effect
OIG released reports pressing for reduced Medicaid payments on DME. Meanwhile, CMS delayed again the face-to-face requirement for DME reimbursement and updated its oxygen supplier policy. A new policy at insurer Cigna took effect to require genetic counseling prior to genetic testing for certain conditions.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.